Found: 16
Select item for more details and to access through your institution.
Polatuzumab vedotin, venetoclax, and an anti‐CD20 monoclonal antibody in relapsed/refractory B‐cell non‐Hodgkin lymphoma.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 7, p. 1281, doi. 10.1002/ajh.27341
- By:
- Publication type:
- Article
Survival following salvage therapy for primary refractory peripheral T‐cell lymphomas (PTCL).
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 3, p. 394, doi. 10.1002/ajh.24992
- By:
- Publication type:
- Article
Taking a BiTE out of Lymphoma: Bispecific Antibodies in B-Cell Non-Hodgkin Lymphoma.
- Published in:
- Cancers, 2024, v. 16, n. 9, p. 1724, doi. 10.3390/cancers16091724
- By:
- Publication type:
- Article
Follicular Lymphoma: Recent and Emerging Therapies, Treatment Strategies, and Remaining Unmet Needs.
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. e1236, doi. 10.1634/theoncologist.2019-0138
- By:
- Publication type:
- Article
ABCL-339: Clinical Activity of Loncastuximab Tesirine (Lonca) Plus Ibrutinib in Non-Hodgkin Lymphoma: Updated LOTIS-3 Phase 1 Results.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S392, doi. 10.1016/S2152-2650(21)01890-5
- By:
- Publication type:
- Article
Poster: ABCL-339: Clinical Activity of Loncastuximab Tesirine (Lonca) Plus Ibrutinib in Non-Hodgkin Lymphoma: Updated LOTIS-3 Phase 1 Results.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S238, doi. 10.1016/S2152-2650(21)01496-8
- By:
- Publication type:
- Article
Evaluating the Role of Novel Oncology Agents: Oncology Stewardship in Relapsed/Refractory Diffuse Large B-Cell Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 5, p. 295, doi. 10.1016/j.clml.2020.12.018
- By:
- Publication type:
- Article
Can Next-Generation PI3K Inhibitors Unlock the Full Potential of the Class in Patients With B-Cell Lymphoma?
- Published in:
- 2021
- By:
- Publication type:
- journal article
Evaluating Acalabrutinib In The Treatment Of Mantle Cell Lymphoma: Design, Development, And Place In Therapy.
- Published in:
- OncoTargets & Therapy, 2019, v. 12, p. 8003, doi. 10.2147/OTT.S155778
- By:
- Publication type:
- Article
The physical exam's role in determining dose-limiting toxicity prior to immunochemotherapy administration in lymphoma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 3, p. 601, doi. 10.1177/10781552221075224
- By:
- Publication type:
- Article
Integrative analysis of clinicopathological features defines novel prognostic models for mantle cell lymphoma in the immunochemotherapy era: a report from The North American Mantle Cell Lymphoma Consortium.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01520-7
- By:
- Publication type:
- Article
Zanubrutinib monotherapy in relapsed/refractory mantle cell lymphoma: a pooled analysis of two clinical trials.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01174-3
- By:
- Publication type:
- Article
Multicentre retrospective study of intravascular large B‐cell lymphoma treated at academic institutions within the United States.
- Published in:
- British Journal of Haematology, 2019, v. 186, n. 2, p. 255, doi. 10.1111/bjh.15923
- By:
- Publication type:
- Article
COVID-19 infection outcomes in patients receiving CD20 targeting T-cell engaging bispecific antibodies for B-cell non-Hodgkin lymphoma.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 9, p. 2635, doi. 10.1007/s00277-023-05315-1
- By:
- Publication type:
- Article
Germline variants discovered in lymphoma patients undergoing tumor profiling: a case series.
- Published in:
- Familial Cancer, 2021, v. 20, n. 1, p. 61, doi. 10.1007/s10689-020-00192-3
- By:
- Publication type:
- Article
Long‐term outcomes of second‐line versus later‐line zanubrutinib treatment in patients with relapsed/refractory mantle cell lymphoma: An updated pooled analysis.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 18, p. 18643, doi. 10.1002/cam4.6473
- By:
- Publication type:
- Article